hexarelin
Selected indexed studies
- Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway. (Eur J Med Res, 2023) [PMID:37710348]
- The cardiovascular action of hexarelin. (J Geriatr Cardiol, 2014) [PMID:25278975]
- Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation. (Microvasc Res, 2022) [PMID:34856183]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway. (2023) pubmed
- The cardiovascular action of hexarelin. (2014) pubmed
- Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation. (2022) pubmed
- Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy via the regulation of autophagy. (2019) pubmed
- Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases. (2015) pubmed
- Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury. (2021) pubmed
- Hexarelin: a multi-receptor peptide. (2008) pubmed
- Hexarelin as a test of pituitary reserve in patients with pituitary disease. (1999) pubmed
- Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE(-/-) mice. (2019) pubmed
- Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death. (2001) pubmed